1. A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. (4th December 2012) Authors: Popat, Rakesh; Plesner, Torben; Davies, Faith; Cook, Gordon; Cook, Mark; Elliott, Peter; Jacobson, Eric; Gumbleton, Todd; Oakervee, Heather; Cavenagh, Jamie Journal: British journal of haematology Issue: Volume 160:Number 5(2013:Mar.) Page Start: 714 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗